Study of Metabolic Problems in Patients With Adrenal Tumors Using CT Scan Images

What this Trial Is About

This research focuses on patients with adrenal tumors and aims to study metabolic complications using existing radiological images. It is a retrospective observational study that collects data already available at participating centers. The purpose is to analyze CT images through radiomics to help differentiate between benign and malignant adrenal masses, and to explore associations with biological markers and disease progression. Patients included in the study have adrenal tumors and have undergone abdominal CT scans whose images are stored in DICOM format. These images, along with clinical and histological data when available, will be pseudonymized and securely transferred to a central center for radiomics analysis. This process will not affect the patients medical care as it uses past data only. Participants involvement consists of use of their previously collected CT images and medical information. The research team will measure diagnostic accuracy of radiomics parameters for tumor classification and examine their relation to Ki67 values, Weiss score, and occurrence of distant metastasis. Data security is ensured by restricting image access to authorized personnel only. The study is expected to complete within about one year from start date in 2025.

Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images